Risk Factors of Epistaxis Recurrence in Adults
ConditionEpistaxis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Grenoble
About this trial
We study all patients admitted to the Emergency Department in the Institution between 01/2022 and 07/2023. The information about the recurrence of nose bleeding was searched on their medical file and by calling the patient to confirm ou get the information. Thus, several potentiel risk factors were studied.
The relation between recurrence and those factors were studied at first individually and then all the significant ones were analyzed with a multivarious statistical test.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient who is admitted at the emergency department between 01/2022 and 07/2023 for nose bleeding.
Age over 18 yo
Disqualifiers
Opposition to be included
Patient who has not his willness to provide opposition to participate.opposition
Trial population
All the patientswho are admitted at the emergency department between 01/2022 and 07/2023
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
145 Participants
are grouped into 1 trial groupGroup A: Patient with nose bleeding
Trial outcomes
Primary outcomes
1
Survival without bleeding
Measuring the delay between the first epistaxis and a recurrence.
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: